Industry Presentations
Polycythemia Vera Treatment
A Treatment Option for Adult Patients with Polycythemia Vera (PV
Speakers: James McCloskey, MD Duration: 60 minutes
Presented on: January 16, 2024
*This session is not eligible for AMA PRA Category 1 CreditsTM
Data in HR+, HER2-, high-risk EBC
Data in HR+, HER2-, high-risk EBC: Discover the potential impact on your clinical approach
Speakers: Joyce O’Shaughnessy, MD Duration: 60 minutes
Presented on: January 19, 2024
*This session is not eligible for AMA PRA Category 1 CreditsTM
Efficacy and Tolerability Data of a Treatment Option in mHSPC and nmCRPC
Efficacy and Tolerability Data of a Treatment Option in mHSPC and nmCRPC
Speakers: Neal D. Shore, MD, FACSEdwin M. Posadas, MD, FACP, KM Duration: 60 minutes
Presented on: January 19, 2024
*This session is not eligible for AMA PRA Category 1 CreditsTM
A First-Line Precision Therapy for mNSCLC
Shattering the Status Quo: A First-Line Precision Therapy for mNSCLC
Speakers: Mark A. Socinski, MD, Executive Medical Director, Florida Hospital Cancer Institute, Orlando, FL Duration: 60 minutes
Presented on: February 12, 2024
*This session is not eligible for AMA PRA Category 1 CreditsTM